Results 11 to 20 of about 10,344 (170)
Progressive multifocal leukoencephalopathy
Chinese Journal of Contemporary Neurology and Neurosurgery, 2020 doi：10.3969/j.issn.1672⁃6731.2020.03 ...
Xiao⁃ling YAN
doaj +2 more sources
Progressive Multifocal Leukoencephalopathy in an Immunocompetent Patient [PDF]
Case Reports in Neurology, 2013 Background: Progressive multifocal leukoencephalopathy (PML) is a rapidly progressive, potentially fatal, demyelinating disease affecting immunosuppressed patients.
Krisztina K. Johansen +3 more
doaj +3 more sources
Progressive multifocal leukoencephalopathy [PDF]
Neurology, 2002 A 58-year-old woman admitted to the hospital had a 3-month history of progressive neurologic deterioration characterized by severe global aphasia and bilateral limb weakness, greater on the right. The patient had a 10-year history of systemic lupus erythematosus (SLE). Polyarthritis had been present for 6 weeks before the …
Henderson, R. D. +3 more
openaire +4 more sources
Progressive multifocal leukoencephalopathy [PDF]
Tidsskrift for Den norske legeforening, 2017 Progressive multifocal leukoencephalopathy is a rare, opportunistic infection of the central nervous system caused by the John Cunningham virus (JCV). There is no effective antiviral treatment available, and restoring immunocompetence is essential for survival. If this occurs too quickly, however, the inflammatory response may prove fatal.
Christine Hanssen Rinaldo +2 more
openaire +2 more sources
Progressive multifocal leukoencephalopathy [PDF]
Current Neurology and Neuroscience Reports, 2000 Progressive multifocal leukoencephalopathy (PML) was a rare disease until the advent of the HIV/AIDS pandemic. Recent interest in the disorder has been spurred by its appearance in patients treated with the monoclonal antibodies natalizumab and rituximab.
openaire +5 more sources
Atezolizumab Treatment for Progressive Multifocal Leukoencephalopathy
Emerging Infectious Diseases, 2022 Atezolizumab successfully reinvigorated JC virus immunity in a patient in Belgium with progressive multifocal leukoencephalopathy, as demonstrated by clinical, virologic, and radiologic response to treatment.
Nicolas Lambert +4 more
doaj +1 more source
AIDS Research and Therapy, 2020 The human neurotropic virus JC Polyomavirus, a member of the Polyomaviridae family, is the opportunistic infectious agent causing progressive multifocal leukoencephalopathy, typically in immunocompromised individuals.
Vijay Harypursat +3 more
doaj +1 more source
Asymptomatic progressive multifocal leukoencephalopathy: a case report and review of the literature
Journal of Medical Case Reports, 2018 Background We report the development of asymptomatic progressive multifocal leukoencephalopathy in a patient with multiple sclerosis on natalizumab therapy.
Yinan Zhang +2 more
doaj +1 more source
Cerebral lesions in hematological malignancies: a case report
Journal of Medical Case Reports, 2021 Background Progressive multifocal leukoencephalopathy is a rare central nervous system disease, resulting from reactivation of latent John Cunningham virus.
Nicoletta D’Ettore +3 more
doaj +1 more source
Progressive Multifocal Leukoencephalopathy [PDF]
F1000Research, 2015 Progressive multifocal leukoencephalopathy (PML) is a devastating demyelinating disease with significant morbidity and mortality and no effective, targeted therapies. It is most often observed in association with abnormalities of cell-mediated immunity, in particular human immunodeficiency virus (HIV) infection, but also occurs in association with ...
Adang, Laura, Berger, Joseph
openaire +2 more sources